Key result
The presence of antiphospholipid antibodies was strongly associated with an increased risk of pregnancy-associated deep venous thrombosis.
Why the study?
What is the prevalence of DVT in pregnancy and its association with thrombophilia markers in an Indian cohort?
Observational (n=34,720)
Yes
What is the prevalence of DVT in pregnancy and its association with thrombophilia markers in an Indian cohort?
Answers are grounded in this paper and cite their sources.
In an Indian cohort, pregnancy-associated DVT had a prevalence of 0.1% and was strongly associated with both acquired and heritable thrombophilias, particularly antiphospholipid antibodies and Protein S deficiency.
Background Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. Methods We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss. Results The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%). Conclusion We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2007) conducted an observational in Deep venous thrombosis in pregnancy (n=34,720). Antiphospholipid antibodies (APA) vs. Absence of antiphospholipid antibodies was evaluated on Pregnancy-associated deep venous thrombosis (RR 7.4, 95% CI 4.3-11.3, p=<0.05). The presence of antiphospholipid antibodies was strongly associated with an increased risk of pregnancy-associated deep venous thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: